Article
Lesion-specific suppression of YAP/TAZ by biomimetic nanodrug ameliorates atherosclerosis development
2023-04-26
Abstract excerpt
Atherosclerosis, characterized by the buildup of lipid-rich plaque on the vessel wall, is the primary cause of myocardial infarction and ischemic stroke. Recent studies have demonstrated that dysregulation of yes-associated protein 1 (YAP) and transcriptional coactivator with PDZ-binding domain (TAZ) contributes to plaque development, making YAP/TAZ potential therapeutic targets. However, systemic modulation of YA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6b13acd5-5a0d-5f65-ae92-81ca0ee1001f
- DOI
- 10.1101/2023.04.24.537992
